Comment: Propofol infusion syndrome in critically ill patients [1] (multiple letters)

Annals of Pharmacotherapy

Volumn 37, Issue 4, 2003, Pages 594-595

  Pulsford, A H ^a   Kang, Tep M ^b  

^a ASTRAZENECA   (United Kingdom)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL;

ASYSTOLE; BRADYCARDIA; CAUSE OF DEATH; CLINICAL FEATURE; CORRELATION ANALYSIS; CRITICAL ILLNESS; DOSE RESPONSE; DRUG INFUSION; DRUG MEGADOSE; DRUG UTILIZATION; FATTY LIVER; HEART ARRHYTHMIA; HEART FAILURE; HEPATOMEGALY; HUMAN; HYPERLIPIDEMIA; LETTER; LONG TERM CARE; METABOLIC ACIDOSIS; MYOGLOBINURIA; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RHABDOMYOLYSIS; SYNDROME;

EID: 0037380785     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1a321a     Document Type: Letter

References (0)